Laddar...
Periodontal disease in a patient receiving Bevacizumab: a case report
<p>Abstract</p> <p>Introduction</p> <p>Bevacizumab is a monoclonal antibody that inhibits the action of vascular endothelial growth factor (VEGF) thereby acting as an angiogenesis inhibitor. As a result, supply of oxygen and nutrients to tissues is impaired and tumour c...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BMC
2008-02-01
|
| Serie: | Journal of Medical Case Reports |
| Länkar: | http://www.jmedicalcasereports.com/content/2/1/47 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|